Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis
Clinical trial NCT00333411 · COMPLETED
Trial details
- NCT number
- NCT00333411
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2008-06-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.